Costs of fragility hip fractures globally: a systematic review and meta-regression analysis
Tóm tắt
Purpose This study was conducted in order to systematically review the costs of hip fractures globally and identify drivers of differences in costs. Methods A systematic review was conducted to identify studies reporting patient level fragility hip fracture costs between 1990 and 2015. We extracted data on the participants and costs from these studies. Cost data concerning the index hospitalisation were pooled, and a meta-regression was used to examine its potential drivers. We also pooled data on the first-year costs following hip fracture and considered healthcare, social care as well as other cost categories if reported by studies. Results One hundred and thirteen studies reported costs of hip fracture based on patient level data. Patients developing complications as well as patients enrolled in intervention arms of comparative studies were found to have significantly higher costs compared to the controls. The pooled estimate of the cost for the index hospitalisation was $10,075. Health and social care costs at 12 months were $43,669 with inpatient costs being their major driver. Meta-regression analysis identified age, gender and geographic region as being significantly associated with the differences in costs for the index hospitalisation. Conclusion Hip fracture poses a significant economic burden and variation exists in their costs across different regions. We found that there was a considerable variation across studies in terms of study design, methodology, follow-up period, costs considered and results reported that highlights the need for more standardisation in this area of research.
Tài liệu tham khảo
Cooper C (1997) Advances in the epidemiology, prevention, and treatment of osteoporosis and fractures. The crippling consequences of fractures and their impact on quality of life. Am J Med 103(2):S12–S19. doi:10.1016/S0002-9343(97)90022-X
Johnell O, Kanis JA (2006) An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int 17(12):1726–1733. doi:10.1007/s00198-006-0172-4
Leal J, Gray AM, Prieto-Alhambra D, Arden NK, Cooper C, Javaid MK, Judge A (2016) Impact of hip fracture on hospital care costs: a population-based study. Osteoporos Int 27(2):549–558. doi:10.1007/s00198-015-3277-9
Woolf AD, Pfleger B (2003) Burden of major musculoskeletal conditions. Bull World Health Organ 81(9):646–656
Dhanwal DK, Dennison EM, Harvey NC, Cooper C (2011) Epidemiology of hip fracture: worldwide geographic variation. Indian J Orthop 45(1):15–22. doi:10.4103/0019-5413.73656
Cole ZA, Dennison EM, Cooper C (2008) Osteoporosis epidemiology update. Curr Rheumatol Rep 10(2):92–96. doi:10.1007/s11926-008-0017-6
Kanis JA, Oden A, Johnell O, Johansson H, De Laet C, Brown J, Burckhardt P, Cooper C, Christiansen C, Cummings S, Eisman JA, Fujiwara S, Glüer C, Goltzman D, Hans D, Krieg M-A, La Croix A, McCloskey E, Mellstrom D, Melton LJ, Pols H, Reeve J, Sanders K, Schott A-M, Silman A, Torgerson D, van Staa T, Watts NB, Yoshimura N (2007) The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int 18(8):1033–1046. doi:10.1007/s00198-007-0343-y
Järvinen TLN, Sievänen H, Khan KM, Heinonen A, Kannus P (2008) Shifting the focus in fracture prevention from osteoporosis to falls. BMJ 336(7636):124–126
Keen RW (2014) Pathophysiology of osteoporosis. In: Clunie GPR, Keen RW (eds) Osteoporosis, 2nd edn. Oxford University Press, Oxford. doi:10.1093/med/9780198713340.003.0001
Borgström F, Johnell O, Kanis JA, Jönsson B, Rehnberg C (2006) At what hip fracture risk is it cost-effective to treat? Osteoporos Int 17(10):1459–1471. doi:10.1007/s00198-006-0107-0
Lim SS, Vos T, Flaxman AD et al (2012) A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380(9859):2224–2260. doi:10.1016/S0140-6736(12)61766-8
Chia PH, Gualano L, Seevanayagam S, Weinberg L (2013) Outcomes following fractured neck of femur in an Australian metropolitan teaching hospital. Bone Joint Res 2(8):162–168. doi:10.1302/2046-3758.28.2000177
Panula J, Pihlajamäki H, Mattila VM, Jaatinen P, Vahlberg T, Aarnio P, Kivelä S-L (2011) Mortality and cause of death in hip fracture patients aged 65 or older—a population-based study. BMC Musculoskelet Disord 12(1):105. doi:10.1186/1471-2474-12-105
Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339. doi:10.1136/bmj.b2535
The World Bank (2015) GDP per capita (current US$). The World Bank, http://data.worldbank.org/indicator/NY.GDP.PCAP.CD
The World Bank (2015) Health expenditure per capita (current US$). The World Bank, http://data.worldbank.org/indicator/SH.XPD.PCAP
The World Bank (2015) Health expenditure, public (% of total health expenditure) http://data.worldbank.org/indicator/SH.XPD.PUBL
Luengo-Fernandez R, Gray AM, Rothwell PM (2009) Costs of stroke using patient-level data: a critical review of the literature. Stroke 40(2):e18–e23. doi:10.1161/strokeaha.108.529776
The World Bank (2015) GDP deflator (base year varies by country). The World Bank, http://data.worldbank.org/indicator/NY.GDP.DEFL.ZS?end=2015&start=1989
The World Bank (2015) PPP conversion factor, GDP (LCU per international $). The World Bank, http://data.worldbank.org/indicator/PA.NUS.PPP
Deeks JJ, Higgins JPT, Altman DG (2011) Chapter 9: analysing data and undertaking meta-analyses. In: Higgins JPT, Green S (eds) Cochrane handbook for systematic reviews of interventions version 5.1.0. The Cochrane Collaboration, the Cochrane Collaboration
French FH, Torgerson DJ, Porter RW (1995) Cost analysis of fracture of the neck of femur. Age Ageing 24(3):185–189
Edwards C, Counsell A, Boulton C, Moran CG (2008) Early infection after hip fracture surgery: risk factors, costs and outcome. J Bone Joint Surg Br 90(6):770–777. doi:10.1302/0301-620X.90B6.20194
Lawrence TM, White CT, Wenn R, Moran CG (2005) The current hospital costs of treating hip fractures. Inj Int J Care Inj 36(1):88–91. doi:10.1016/j.injury.2004.06.015
Deeks JJ, Higgins JPT, Altman DG (2008) Analysing data and undertaking meta-analyses. In: Cochrane handbook for systematic reviews of interventions. Wiley, Chichester, pp 243–296. doi:10.1002/9780470712184.ch9
Baladi J-F, Menon D, Otten N (1998) Use of economic evaluation guidelines: 2 years’ experience in Canada. Health Econ 7(3):221–227. doi:10.1002/(SICI)1099-1050(199805)7:3<221::AID-HEC341>3.0.CO;2-N
Husereau D, Drummond M, Petrou S, Carswell C, Moher D, Greenberg D, Augustovski F, Briggs AH, Mauskopf J, Loder E (2013) Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. BMJ: British Medical Journal 346. doi:10.1136/bmj.f1049
Drummond MF, Jefferson TO (1996) Guidelines for authors and peer reviewers of economic submissions to the BMJ. BMJ 313(7052):275–283. doi:10.1136/bmj.313.7052.275
Mogyorosy Z, Smith P (2005) The main methodological issues in costing health care services: a literature review. University of York, York
Byford S, Raftery J (1998) Perspectives in economic evaluation. BMJ: Br Med J 316(7143):1529–1530
Menzin J, Wygant G, Hauch O, Jackel J, Friedman M (2008) One-year costs of ischemic heart disease among patients with acute coronary syndromes: findings from a multi-employer claims database. Curr Med Res Opin 24(2):461–468. doi:10.1185/030079908X261096
Mercaldi CJ, Siu K, Sander SD, Walker DR, Wu Y, Li Q, Wu N (2012) Long-term costs of ischemic stroke and major bleeding events among Medicare patients with nonvalvular atrial fibrillation. Cardiol Res Pract 2012:13. doi:10.1155/2012/645469